Skip to content

Using mHealth to Promote Post-Menstrual Regulation Contraceptive Uptake and Continuation in Bangladesh

Using mHealth to Promote Post-Menstrual Regulation Contraceptive Uptake and Continuation in the Sylhet, Chittagong and Dhaka Regions of Bangladesh

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02579785
Enrollment
972
Registered
2015-10-20
Start date
2015-12-19
Completion date
2016-07-15
Last updated
2021-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Contraception, Post-abortion

Keywords

Family Planning, Abortion, mHealth, Behaviour Change Communication, Menstrual Regulation, Postabortion, Bangladesh

Brief summary

The purpose of this study is to assess whether a mobile phone intervention can be effectively used to improve post menstrual regulation contraceptive uptake and continuation in Bangladesh. The study will consist of two phases: Phase I: A formative phase to understand barriers to post-abortion contraceptive uptake and continuation and the content and modality of messages most appropriate for women in the study areas; and Phase II: An RCT will be conducted to test the effectiveness of the mHealth intervention developed during the formative phase on contraceptive use.

Detailed description

The proposed study aims to develop and evaluate a mHealth intervention to promote post-abortion contraceptive uptake and continuation among menstrual regulation clients in the Sylhet, Chittagong and Dhaka regions of Bangladesh. The aim of the formative phase of the study is to develop an interactive two-way messaging service for post-MR clients. The messaging service will deliver information relating to the women's contraceptive method of choice as well as information about other modern contraceptive methods. This part of the study will focus on determining the modality, content, timing, language and acceptability of messaging services for post menstrual regulation clients. The aim of the RCT phase is to measure the effect of mHealth on uptake or switching to long-acting reversible contraceptives at the 4 month and 12 month follow ups. The investigators expect mHealth to have a positive effect on uptake and a negative effect on discontinuation rates of contraceptive users.

Interventions

BEHAVIORALMhealth intervention

A series of ten automated interactive voice messages will be delivered to the participant's mobile phone over a period of 4 months. Messages will be targeted to the method of contraception the participant is using (no-method, condoms, pills, injectable, implant, copper coil). Messages will support uptake of contraception among no-method users. Messages will support existing users to continue their method and to use it correctly and will also encourage participants who are not happy with their method to switch to a different method. All messages will end with five options: Press 1 to repeat the message, press 2 to listen to recorded information about methods of contraception, press 3 to speak to a counsellor, press 4 to tell me you're fine, press 5 to stop receiving these messages.

Sponsors

Ipas
CollaboratorOTHER
London School of Hygiene and Tropical Medicine
CollaboratorOTHER
Marie Stopes International
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Received menstrual regulation services using Manual Vacuum Aspiration (MVA) or Medical Abortion (MA) * Have a personal mobile telephone * Agree to receive messages on mobile about family planning * Provide informed consent for participation

Exclusion criteria

* Received anaesthesia for their MVA procedure * Intend to become pregnant within the next six months * Intend to use, or for partner to use, a permanent method of contraception (i.e. sterilisation) within the next six months

Design outcomes

Primary

MeasureTime frameDescription
Use of long acting and reversible contraceptive at 4 months4 monthsProportion of subjects that self-report using a long acting and reversible contraceptive (coil or implant)

Secondary

MeasureTime frameDescription
Use of long acting and reversible contraceptive at 2 weeks and 12 months2 weeks and 12 monthsProportion of subjects that self-report using a long acting and reversible contraceptive (coil or implant)
Use of any modern method at 2 weeks, 4 months and 12 months2 weeks, 4 months and 12 monthsThe proportion of subjects that self report using any effective modern contraceptive method: Modern contraceptive methods are defined according to the WHO as those associated with \<10% 12 month pregnancy rates (WHO, 2011)
Pregnancy4 months and 12 monthsProportion of subjects pregnant that self-report pregnancy at the time of follow-up
Menstrual Regulation4 months and 12 monthsProportion of subjects that self report having had an MR procedure since baseline

Countries

Bangladesh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026